Cipla Limited

FDA inspection history across 3 sites, 2018 to 2023

5
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2018: one Form 483; 2022: two Form 483s; 2023: two Form 483s and one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018One Form 483, at Pithampur, India.
  2. 2022–23Four Form 483s and one warning letter, at Pithampur Dhar, India; Indore SEZ, Pithampur, India and Pithampur, India.
  3. 2023The longest 483 on file: 8 observations over 23 pages at Pithampur Dhar, India.

Cited most

Across all Cipla Limited observations on file

The complete Cipla Limited file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Also: one document not tied to a site.

Documents

6 on file, newest first
DateDocumentPrice
2023-11-17Warning letter Warning letter$99
2023-02-17483 Form 483$99
2023-02-06483 Form 483$99
2022-07-01483 Form 483$99
2022-07-01483 Form 483$99
2018-04-13483 Form 483$99

FEI number 3008581988 · most recent document Nov 17, 2023

About Cipla Limited

How many FDA Form 483s has Cipla Limited received?

FDA Intel has 5 Form 483s on file for Cipla Limited; the most recent is dated Feb 17, 2023.

When was Cipla Limited last inspected by FDA?

The most recent FDA inspection document on file for Cipla Limited is a Form 483 dated Feb 17, 2023, for the site in Pithampur Dhar, India.

What did FDA cite at Cipla Limited?

The regulations cited most in the observations on file for Cipla Limited are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.166 (Stability testing), 2 times.

Has Cipla Limited received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Cipla Limited; the most recent is dated Nov 17, 2023.